Skip to Content Skip to Content

School of Veterinary Medicine

Visit the School's Site
Penn Study Shows How Some Intestinal Cells Resist Chemotherapy and Radiation

Penn Study Shows How Some Intestinal Cells Resist Chemotherapy and Radiation

When treating cancer with chemotherapy and radiation, decisions about dose must walk a fine line between attacking cancerous cells and preserving healthy ones. Overly aggressive radiation therapy to the torso, for example, can damage the epithelial cells that line the intestines, leading to chronic gastrointestinal problems.

Katherine Unger Baillie

Penn to Celebrate Ribbon Cutting for New Innovation Hub, Pennovation Center

Penn to Celebrate Ribbon Cutting for New Innovation Hub, Pennovation Center

University of Pennsylvania President Amy Gutmann and David L. Cohen, chair of Penn’s Board of Trustees, invite Penn students, faculty, staff, alumni, trustees and friends, as well as the region’s business and tech community, to a ribbon-cutting and grand opening ceremony from 12:30 to 4 p.m. on Friday, Oct. 28.
Penn Vet Professor Assists in Effort to Empower Smallholder Farmers

Penn Vet Professor Assists in Effort to Empower Smallholder Farmers

To ensure the global population is food secure, it’s estimated that food production must increase at least 50 percent by 2050. One of the best means to achieve that increase is by boosting yield, that is, producing more food on existing cropland with fewer resources.

Katherine Unger Baillie

Penn: Blinding Disease in Canines and Humans Shares Causative Gene, Pathology

Penn: Blinding Disease in Canines and Humans Shares Causative Gene, Pathology

Ciliopathies are diseases that affect the cilia, sensory organelles that most mammalian cells possess and which play a critical role in many biological functions. One such disease is Senior Løken Syndrome, a rare condition that can involve both a severe kidney disease and the blinding disease Leber congenital amaurosis, or LCA.

Katherine Unger Baillie

Penn Team Identifies Strategy to Reverse the Disease Dyskeratosis Congenita

Penn Team Identifies Strategy to Reverse the Disease Dyskeratosis Congenita

Dyskeratosis congenita, or DC, is a rare, inherited disease for which there are limited treatment options and no cure. Typically diagnosed in childhood, the disorder causes stem cells to fail, leading to significant problems including bone marrow failure, lung fibrosis, dyskeratosis of the skin and intestinal atrophy and inflammation.

Katherine Unger Baillie